Research study Program year 2022 Source: CMS Open Payments

A Phase 3 Randomized Double-Blind Trial of Maintenance With Niraparib

Research payments

$881,762

99 payments

Through program year 2022, $881,762 in research payments was reported against A Phase 3 Randomized Double-Blind Trial of Maintenance With Niraparib, across 99 payments, paid by GlaxoSmithKline, LLC..

Paid by
GlaxoSmithKline, LLC.
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2022 Research $304,031 15
2021 Research $5,934 4
2020 Research $525,381 76
2019 Research $46,415 4

Breakdown

Who paid Research payments · program years 2019–2022
  1. GlaxoSmithKline, LLC. $881,762 99 payments
Who received the money Research payments · program years 2019–2022
  1. Biomedical Research Alliance Of New York LLC Organisation paid for research $295,098 12 payments
  2. Atlantic Health System Organisation paid for research $116,884 4 payments
  3. Stanford University Organisation paid for research $109,912 14 payments
  4. Sarah Cannon Research Institute Organisation paid for research $71,849 8 payments
  5. California Pacific Medical Center 1 Organisation paid for research $55,367 1 payment
  6. US Oncology Research INC-Chicago-United Organisation paid for research $37,264 4 payments
  7. Mayo Clinic Jacksonville Organisation paid for research $32,883 2 payments
  8. Sarah Cannon Research Institute LLC Organisation paid for research $25,668 9 payments
  9. St Vincent Research And Regulatory Affairs Organisation paid for research $23,599 1 payment
  10. Northwestern University Organisation paid for research $20,731 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record